| Biobehavioral Intervention in Gynecologic Oncology Patients (NCT02454036) | Rachel Miller | 2015-06-01 |
| A Study of PEG-somatropin in the Treatment of Children With Idiopathic Short Stature (NCT03221088) | Changchun GeneScience Pharmaceutical Co., Ltd. | 2015-06-01 |
| Freeze-dried vs Fresh Fecal Microbiota Transplantation in Patients With Slow Transit Constipation (NCT02676388) | Jinling Hospital, China | 2015-06-01 |
| Hemodynamic Effects of Intramuscular PDA-002 in Subjects Who Have Diabetic Foot Ulcer With Peripheral Arterial Disease (NCT02460081) | Celularity Incorporated | 2015-06-01 |
| Testis CAB: Cabazitaxel as Salvage Treatment for Cisplatin-resistant Germ Cell Cancer (NCT02478502) | University Hospital, Akershus | 2015-06-01 |
| Targeted Therapy With Gefitinib in Patients With USP8-mutated Cushing's Disease (NCT02484755) | Huashan Hospital | 2015-06-01 |
| Dose Ranging Trial to Determine the Safety and Efficacy of EMA401 in Patients With PHN (NCT02426411) | Spinifex Pharmaceuticals Pty Ltd | 2015-06-01 |
| Psoriasis-Arthritis & Bone Program (NCT02483234) | University of Erlangen-Nürnberg Medical School | 2015-05-31 |
| Determination of Levels of Micafungin in Neonates Suffering From Systemic Candidiasis and/or Candida Meningitis (NCT03421002) | Astellas Pharma Global Development, Inc. | 2015-05-30 |
| An Evaluation of the Effectiveness of a Proprietary Probiotic Blend on Functional Constipation (NCT02418507) | KGK Science Inc. | 2015-05-29 |
| Study of Pembrolizumab in Combination With Chemotherapy for Patients With Advanced Colorectal Cancer (NCT02375672) | Hoosier Cancer Research Network | 2015-05-28 |
| Sequential Regimen of Bendamustine-Debulking Followed by CAL-101 and GA101-Induction and -Maintenance in CLL (CLL2-BCG) (NCT02445131) | German CLL Study Group | 2015-05-28 |
| Tamoxifen Citrate or Z-Endoxifen Hydrochloride in Treating Patients With Locally Advanced or Metastatic, Estrogen Receptor-Positive, HER2-Negative Breast Cancer (NCT02311933) | National Cancer Institute (NCI) | 2015-05-28 |
| Neoadjuvant Pembrolizumab in Combination With Gemcitabine Therapy in Cis-eligible/Ineligible UC Subjects (NCT02365766) | Jason R. Brown | 2015-05-27 |
| Chronic Dosing Cross-Over Study to Assess the Efficacy and Safety of Glycopyrronium (PT001) in Adult Subjects With Intermittent Asthma or Mild to Moderate Persistent Asthma (NCT02433834) | Pearl Therapeutics, Inc. | 2015-05-27 |
| Study to Assess Analgesic Efficacy and Safety of ASP3662 in Subjects With Painful Diabetic Peripheral Neuropathy (NCT02372578) | Astellas Pharma Global Development, Inc. | 2015-05-27 |
| Postoperative Hepatic Arterial Chemotherapy in High-risk Patients as Adjuvant Treatment After Resection of Colorectal Liver Metastases (NCT02494973) | Gustave Roussy, Cancer Campus, Grand Paris | 2015-05-26 |
| Adoptive Transfer of Specific Melanoma Antigens CD8+ T Cells in Metastatic Melanoma Patients: a Phase I/II Study (NCT02424916) | Nantes University Hospital | 2015-05-26 |
| Selinexor Treatment of Refractory Myeloma (NCT02336815) | Karyopharm Therapeutics Inc | 2015-05-26 |
| Selumetinib in Patients Receiving Pemetrexed and Platinum-based Chemotherapy in Advanced or Metastatic KRAS Wildtype or Unknown Non-Squamous NSCLC (NCT02337530) | Canadian Cancer Trials Group | 2015-05-26 |
| Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of JNJ-42756493 (Erdafitinib) in Participants With Advanced Hepatocellular Carcinoma (NCT02421185) | Janssen Research & Development, LLC | 2015-05-25 |
| Sildenafil for the Treatment of Lymphatic Malformations (NCT02335242) | Stanford University | 2015-05-23 |
| Brentuximab Vedotin in High-Risk CD30+ Lymphoma Post Allogeneic Stem Cell Transplantation (AlloSCT) (NCT02169505) | M.D. Anderson Cancer Center | 2015-05-22 |
| Treatment of Renal Angiomyolipomas in Tuberous Sclerosis by Beta-blockers (NCT02104011) | University Hospital, Bordeaux | 2015-05-22 |
| Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed Dose Combination Administered in Patients Infected With Chronic Genotype 1 or 4 HCV for Use in the Peri-Operative Liver Transplantation Setting (NCT02350569) | Gilead Sciences | 2015-05-22 |
| A Pilot Trial to Assess Low-Intensity Ultrasound in Osteoarthritis (NCT02034409) | VA Office of Research and Development | 2015-05-22 |
| Genetically Modified T Cells in Treating Patients With Stage III-IV Non-small Cell Lung Cancer or Mesothelioma (NCT02408016) | Fred Hutchinson Cancer Center | 2015-05-22 |
| Microtransplantation to Treat Refractory or Relapsed Hematologic Malignancies in Younger Patients (NCT02433483) | St. Jude Children's Research Hospital | 2015-05-22 |
| NMDA Enhancer for the Treatment of Mild Alzheimer's Disease (NCT03752463) | Chang Gung Memorial Hospital | 2015-05-22 |
| Trial of pIL-12 Electroporation in Squamous Cell Carcinoma of the Head and Neck (IL12HNSCC) (NCT02345330) | OncoSec Medical Incorporated | 2015-05-21 |
| A Safety and Efficacy Study of LiRIS® in Females With Interstitial Cystitis/Bladder Pain Syndrome (NCT02411110) | Allergan | 2015-05-21 |
| Validation of a Predictive Model of Response to Romiplostim in Patients With IPSS Low or Intermediate-1 Risk MDS and Thrombocytopenia (NCT02335268) | Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH | 2015-05-21 |
| The Potential for Metformin to Improve Tumor Oxygenation in Locally Advanced Cervix Cancer: A Phase II Randomized Trial (NCT02394652) | University Health Network, Toronto | 2015-05-21 |
| Vaccine Therapy in Reducing the Frequency of Cytomegalovirus Events in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant (NCT02396134) | City of Hope Medical Center | 2015-05-21 |
| Bevacizumab + Triplet Treatment for Untreated With Chemotherapy Metastatic Colorectal Cancer (NCT02497157) | Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan | 2015-05-21 |
| Ultrasound-guided Nerve Block: Determination of the Minimal Effective Volume of Local Anesthetic (NCT02438657) | Hopital Foch | 2015-05-21 |
| Everolimus and Letrozole or Hormonal Therapy to Treat Endometrial Cancer (NCT02228681) | GOG Foundation | 2015-05-21 |
| Management of Pain Post Hepatectomy : Infiltration of Local Anesthetics Versus Continuous Spinal Analgesia . (NCT03238430) | University Hospital, Lille | 2015-05-20 |
| Phase II Trial of Alisertib (MLN8237) in Salvage Malignant Mesothelioma (NCT02293005) | M.D. Anderson Cancer Center | 2015-05-20 |
| A Study to Evaluate 3 Dose Schedules of Daratumumab in Participants With Smoldering Multiple Myeloma (NCT02316106) | Janssen Research & Development, LLC | 2015-05-20 |
| Efficacy and Safety of Weekly Subcutaneous MLN1202 in Improving Diabetic Nephropathy in Participants With Macroalbuminuria (NCT02410499) | Takeda | 2015-05-20 |
| Comparison of Low-Dose, Standard-Dose Ticagrelor and Clopidogrel for Inhibition of Platelet Reactivity in Patients With Acute Coronary Syndromes (NCT02319941) | Seung-Jung Park | 2015-05-20 |
| Phase 1/2a Study of Oral BAL101553 in Adult Patients With Solid Tumors or Glioblastoma or High-grade Glioma (NCT02490800) | Basilea Pharmaceutica | 2015-05-20 |
| Pharmaco-immunological Study of Interferon-alpha and Metronomic Cyclophosphamide Association in Neuroendocrine Tumors (NCT02838342) | Centre Hospitalier Universitaire de Besancon | 2015-05-19 |
| Opioid Induced Gait Variability (NCT03121547) | Frederiksberg University Hospital | 2015-05-19 |
| A Long-term Extension of Study RP103-MITO-001 (NCT02023866) to Assess Cysteamine Bitartrate Delayed-release Capsules (RP103) in Children With Inherited Mitochondrial Disease (NCT02473445) | Amgen | 2015-05-19 |
| A Study to Investigate the Pharmacokinetic Interactions Between Simeprevir and Ledipasvir in a Treatment Regimen Consisting of Simeprevir, Sofosbuvir, and Ledipasvir in Treatment-naive Participants With Chronic Hepatitis C Virus Genotype 1 Infection (NCT02421211) | Janssen Sciences Ireland UC | 2015-05-19 |
| Nivolumab Alone or in Combination With Ipilimumab in Treating Patients With Advanced Uterine Leiomyosarcoma (NCT02428192) | National Cancer Institute (NCI) | 2015-05-19 |
| Fenofibrate Treatment in SCI (NCT02455336) | VA Office of Research and Development | 2015-05-18 |
| Genetic Predictors of Analgesic Efficacy of Propranolol for Treating Postoperative Pain (NCT02511483) | McGill University Health Centre/Research Institute of the McGill University Health Centre | 2015-05-18 |
| Omacetaxine in Patients With Intermediate-1 and Higher Risk Myelodysplastic Syndrome (MDS) Post Hypomethylating Agent (HMA) Failure (NCT02159872) | M.D. Anderson Cancer Center | 2015-05-18 |
| A Study of Multiple Doses of Nusinersen (ISIS 396443) Delivered to Infants With Genetically Diagnosed and Presymptomatic Spinal Muscular Atrophy (NCT02386553) | Biogen | 2015-05-18 |
| Ketamine as a Treatment for Post-Traumatic Stress Disorder (PTSD) (NCT02397889) | Icahn School of Medicine at Mount Sinai | 2015-05-18 |
| Shock Wave Therapy for Osteoporosis (NCT02630381) | UMC Utrecht | 2015-05-18 |
| A Study to Determine the Efficacy of ZPL-3893787 in Subjects With Atopic Dermatitis (NCT02424253) | Ziarco Pharma Ltd | 2015-05-18 |
| Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer (NCT02257528) | National Cancer Institute (NCI) | 2015-05-18 |
| A Study of Treatment With RO6864018 in Virologically Suppressed Participants With Chronic Hepatitis B Virus (HBV) Infection (NCT02391805) | Hoffmann-La Roche | 2015-05-17 |
| Switching Regimen in Treating Cirrhotic HCV GT1b Subjects (NCT02583685) | Humanity and Health Research Centre | 2015-05-15 |
| Nitric Oxide-mediated Cardioprotection During Cardiac Surgery With Cardiopulmonary Bypass (NCT03500783) | Tomsk National Research Medical Center of the Russian Academy of Sciences | 2015-05-15 |
| Nintedanib in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors (NCT02399215) | Roswell Park Cancer Institute | 2015-05-15 |
| TILs & Low-Dose IL-2 Therapy Following Cyclophosphamide and Fludarabine in Pleural Mesothelioma Patients (NCT02414945) | University Health Network, Toronto | 2015-05-15 |
| Clinical Trial of Topically-applied Glyceryl Trinitrate (GTN) for the Treatment of Erectile Dysfunction (ED) (NCT02495467) | Futura Medical Developments Ltd. | 2015-05-15 |
| XELOX in Advanced Biliary Tract Carcinoma After Failure of Gemcitabine-based Chemotherapy (NCT02350686) | Samsung Medical Center | 2015-05-14 |
| Role of Enhancing Serotonin Receptors Activity for Sleep Apnea Treatment in Patients With SCI (NCT02458469) | VA Office of Research and Development | 2015-05-14 |
| MDMA-Assisted Psychotherapy for Anxiety Associated With a Life-Threatening Illness (NCT02427568) | Resilient Pharmaceuticals | 2015-05-14 |
| Peer Led Asthma Self Management for Adolescents: PLASMA (NCT02293499) | University of Rochester | 2015-05-14 |
| Nivolumab in Treating Patients With Primary Myelofibrosis, Post-Essential Thrombocythemia Myelofibrosis, or Post-Polycythemia Vera Myelofibrosis (NCT02421354) | M.D. Anderson Cancer Center | 2015-05-14 |
| Topical Phenylephrine Solution in Preventing Oral Mucosa in Bone Marrow Transplant Patients Receiving Cyclophosphamide and Total Body Radiation Therapy (NCT02434146) | University of Wisconsin, Madison | 2015-05-14 |
| Study For Patients With NSCLC EGFR Mutations (Del 19 or L858R +/- T790M) (NCT02349633) | Pfizer | 2015-05-14 |
| Phase II Study of Tipifarnib in Squamous Head and Neck Cancer With HRAS Mutations (NCT02383927) | Kura Oncology, Inc. | 2015-05-13 |
| Evaluation of Ocoxin®-Viusid® in Breast Cancer (NCT03576521) | Catalysis SL | 2015-05-13 |
| National Lung Matrix Trial: Multi-drug Phase II Trial in Non-Small Cell Lung Cancer (NCT02664935) | University of Birmingham | 2015-05-13 |
| EXTEND Exercise Trial (NCT02256111) | Duke University | 2015-05-13 |
| Nivolumab With or Without Ipilimumab in Treating Patients With Refractory Metastatic Anal Canal Cancer (NCT02314169) | National Cancer Institute (NCI) | 2015-05-13 |
| A Dose Range Finding Study to Evaluate the Effect of Bexagliflozin Tablets in Subjects With Type 2 Diabetes Mellitus (NCT02390050) | Theracos | 2015-05-12 |
| Efficacy and Tolerability of Topical LFX453 for External Genital Warts (NCT02482428) | Novartis Pharmaceuticals | 2015-05-12 |
| A Study to Evaluate 5 μg/kg Tbo-filgrastim in Infants, Children and Adolescents With Solid Tumors Without Bone Marrow Involvement (NCT02190721) | Teva Branded Pharmaceutical Products R&D, Inc. | 2015-05-12 |
| Eltrombopag in Combination With Rabbit Anti-thymocyte Globulin/Cyclosporine A in Naive Aplastic Anemia (AA) Subjects (NCT02404025) | Novartis Pharmaceuticals | 2015-05-12 |
| Study of Anlotinib in Patients With Soft Tissue Sarcoma（STS）(ALTER0203) (NCT02449343) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2015-05-12 |
| Safety Study of a Helper Peptide Vaccine Plus Adjuvant Combinations for the Treatment of Melanoma (NCT02425306) | Craig L Slingluff, Jr | 2015-05-12 |
| An Open-label Phase II Study of Lorvotuzumab Mertansine (NCT02420873) | M.D. Anderson Cancer Center | 2015-05-12 |
| Long-Term TARP Vaccination Using a Multi-Epitope TARP Peptide Autologous Dendritic Cell Vaccination in Previously Vaccinated Men on NCI 09-C-0139 (NCT02362464) | National Cancer Institute (NCI) | 2015-05-12 |
| Dose-finding Study of BMS-955176 to Treat HIV-1 Infected Treatment-naive Adults (NCT02415595) | ViiV Healthcare | 2015-05-12 |
| The Safety and Efficacy of Pomalidomide in Combination With Cyclophosphamide and Dexamethasone (PCD) in the Transplant-ineligible Patients With Relapsed and/or Refractory Multiple Myeloma (MM) (NCT03242460) | Kosin University Gospel Hospital | 2015-05-12 |
| Study of Dupilumab in Adult Participants With Active Eosinophilic Esophagitis (EoE) (NCT02379052) | Regeneron Pharmaceuticals | 2015-05-12 |
| A Study to Assess the Safety and the Efficacy of the Combination of TH-302 and Sunitinib in Neuroendocrine Pancreatic Tumours (NCT02402062) | Grupo Espanol de Tumores Neuroendocrinos | 2015-05-11 |
| Autologous Mesenchymal Stromal Cells for Multiple Sclerosis (NCT02495766) | Banc de Sang i Teixits | 2015-05-11 |
| Efficacy and Safety of Nab-Paclitaxel Plus S-1 in the First-line Treatment of Advanced Pancreatic Cancer (NCT03415802) | Aiping Zhou | 2015-05-11 |
| Nintedanib and Capecitabine in Treating Patients With Refractory Metastatic Colorectal Cancer (NCT02393755) | Roswell Park Cancer Institute | 2015-05-08 |
| A Sub-study of BMS-986036 in Subjects With Non-Alcoholic Steatohepatitis (NASH) (NCT03400163) | Bristol-Myers Squibb | 2015-05-08 |
| A Study of BMS-986036 in Subjects With Non-Alcoholic Steatohepatitis (NASH) (NCT02413372) | Bristol-Myers Squibb | 2015-05-08 |
| Phase II Copanlisib in Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL) (NCT02391116) | Bayer | 2015-05-08 |
| Study of Bortezomib,Lenalidomide,Dexamethasone & Elotuzumab in Newly Diagnosed MM (NCT02375555) | Dana-Farber Cancer Institute | 2015-05-07 |
| S1403, Afatinib Dimaleate With or Without Cetuximab in Treating Patients With Newly Diagnosed Stage IV or Recurrent, EGFR Mutation Positive Non-small Cell Lung Cancer (NCT02438722) | SWOG Cancer Research Network | 2015-05-07 |
| Study to Evaluate Antiviral Activity, Safety, and Pharmacokinetics of Repeated Doses of Orally Administered JNJ 53718678 Against Respiratory Syncytial Virus Infection. (NCT02387606) | Janssen Sciences Ireland UC | 2015-05-07 |
| Nintedanib in Molecularly Selected Patients With Advanced Non-Small Cell Lung Cancer (NCT02299141) | Washington University School of Medicine | 2015-05-07 |
| Safety and Efficacy of Entospletinib With Vincristine and Dexamethasone in Adults With Relapsed or Refractory Acute Lymphoblastic Leukemia (ALL) (NCT02404220) | Gilead Sciences | 2015-05-06 |
| Sequential Regimen of Bendamustine-Debulking Followed by ABT-199 and GA101-Induction and -Maintenance in CLL (CLL2-BAG) (NCT02401503) | German CLL Study Group | 2015-05-06 |
| Study of Intravitreal REGN2176-3 in Participants With Neovascular ("Wet") Age-Related Macular Degeneration (AMD) (NCT02418754) | Regeneron Pharmaceuticals | 2015-05-05 |
| RTA 408 Capsules in Patients With Mitochondrial Myopathy - MOTOR (NCT02255422) | Biogen | 2015-05-05 |